Pneumonia

last authored: Feb 2010, David LaPierre
last reviewed:

 

 

Introduction

Pneumonia, or infection of the lower respiratory tract, is one of the most important causes of death, especially during adult years. It can be caused by a number of pathogens, including bacteria, viruses, fungi, protozoans, and parasites.

normal lung on left; bronchopneumonia (arrows) on right.

courtesy of Dr Zhaolin Xu, Department of Pathology, Dalhousie University

As it is often readily curable, every health care provider should be on the lookout for it, and every physician should know how to rapidly diagnose and treat pneumonia.

 

 

 

 

 

 

 

 

 

 

 

 

The Case of Henry C

Henry Chu is a...

return to top

 

 

 

Causes and Risk Factors

Risk factors for pneumonia include:

 

  • most common pathogens
  • bacteria
  • viruses

most common pathogens

The following pathogens represent the most common causes of pneumonia in different populations:

 

community-acquired in healthy adults

community-acquired in elderly/
comorbidities/nursing home

nosocomial

HIV-associated

alcoholic

ventilator-associated

  • Pseudomonas
  • Klebsiella
  • Serratia
  • Enterobacter
  • Citrobacter
  • Stenotrophomonas
  • Acinetobacter
  • Burkholderia
  • MRSA

immunocompromised

  • bacterial
  • tuberculosis
  • fungal
  • PJP
  • Nocardia
  • viral
  • toxoplasma, if heart transplant

 

 

return to top

 

 

 

Pathophysiology

Under normal circumstances, the lungs are sterile. Pathogens can enter through inhalation, by hematogenous spread, from a contiguous focus of infection, or most commonly by aspiration of oropharyngeal secretions (almost 50% of healthy men aspirate some oropharyngeal contents during sleep). Infection can also follow inhalation of aerosolized droplets, as occurs with tuberculosis.

 

Defenses against pulmonary colonization include cough, mucociliary clearance, and other innate immune defenses. Impaired normal defense mechanisms frequently contribute to the development of pneumonia. These can include:

 

Infection can spread along airways and through alveolar walls, and exudative inflammation results.

 

Lobar Pneumonia:

return to top

 

 

 

History and Physical Exam

A thorough history and physical can help diagnose pneumonia and also distinguish among different pathogens.

 

  • history
  • physical exam

History

Respiratory symptoms of pneumonia include:

  • cough
    • persistent, hacking - Mycoplasma
  • sputum production
  • dyspnea (shortness of breath)
  • chest pain, especially pleuritic
  • fever
  • malaise
  • absence of rhinorrhea or sore throat

A history of rhinitis or pharyngitis suggests respiratory virus, Mycoplasma, or Chlamydia. Abrupt onset of myalgia, arthralgia, headache, and fever are commonly seen in influenza virus infection.

 

Abrupt onset of myalgias, arthralgia, headache, and fever suggest influenza or mycoplasma.

 

Duration of symptoms is a critical piece of information:

  • pneumococcal, mycoplasma, or virual or viral disease is usually acute, with symptoms lasting for hours or days.
  • Symptoms lasting 10 days or longer are rarely caused by common bacterial pathogens and should raise suspicion of mycobacterium, fungal, or anaerobic pneumonia, and/or the presence of underlying disease.

Review of symptoms

  • diarrhea - suggests Legionella
  • altered mental status - ?meningitis

 

past medical history

  • asthma
  • dementia
  • immunosupression

return to top

 

 

 

Investigations

  • lab investigations
  • diagnostic imaging

Lab Investigations

 

blood tests

  • CBCD: usual elevated white cell count, with left shift; higher for bacterial infection
  • lytes
  • urea, sCR
  • troponin/CK
  • AST, ALT, ALP,
  • bili: modest increases in conjugated bilirubin are seen in many bacterial infections
  • C-reactive protein: monitoring severity of infection and treatment response
  • blood culture: will be positive for 20-30% of people with bacterial pneumonia.

 

nasopharyngeal swab: influenza, parainfluenza, metapneumovirus, RSV, adenovirus

 

sputum smear and culture: must be done carefully to avoid contamination by oropharyngeal flora. Both false negatives and false positives are common and should be interpreted carefully.

  • gram stains
  • Gomori's Methenamine Silver (GMS stain)
  • PAS/diastase stain
  • Ziehl-Neelsen stain for mycobacteria: should be done unless diagnosis of acute bacterial pneumonia is clear
  • viral inclusions

 

 

other tests:

  • urinalysis
  • tuberculin skin test
  • lumbar puncture should be done in patients with penumonia and confusion to rule out meningitis
  • mycoplasma IgM
  • tissue biopsy can be very helpful, but its invasiveness is an important consideration.

return to top

 

 

 

Differential Diagnosis

The differential diagnosis of pneumonia includes:

return to top

 

 

 

Treatments

  • immediate
  • community-acquired
  • nosocomial
  • nursing home

Immediate Treatments

As with any patient, it is important to begin by treating the vitals, or ABCs, of the patient. This includes, as necessary:

  • oxygen administration and monitoring of saturation
  • positioning
  • IV access
  • salbutamol/Ventolin

 

For hospitalized patients, length of stay has been shown (Carratala et al, 2012) to be minimized by a clinical pathway prompting:

return to top

 

 

 

Consequences and Course

Complications of pneumonia include:

Prognosis can be predicted with scoring tools, such as the Pneumonia Severity Index (PSI) and the CURB-65 and CRB-65. All three appear to be similarly accurate (Ochoa-Gondar O et al, 2011).

Increased mortality occurs in patients with:

return to top

 

 

 

 

Resources and References

Carratala J et al. 2012. Effect of a 3-Step Critical Pathway to Reduce Duration of Intravenous Antibiotic Therapy and Length of Stay in Community-Acquired Pneumonia: A Randomized Controlled TrialA 3-Step Critical Pathway for CAP. Arch Intern Med. 172(12):922-8.

Harris J et al. 2010. British Thoracic Society guidelines for the management of community acquired pneumonia in children: update 2011. Thorax. 66 Suppl 2:ii1-23.

Jung YJ, et al. 2010. Effect of vancomycin plus rifampicin in the treatment of nosocomial methicillin-resistant Staphylococcus aureus pneumonia. Crit Care Med ;38(1):175-180.

 

Meijvis SC et al. 2011. Dexamethasone and length of hospital stay in patients with community-acquired pneumonia. Lancet 377(9782):2023-2030.

 

Nazarian et al. 2009. Clinical policy: Critical issues in the management of adult patients presenting to the emergency department with community-acquired pneumonia. Ann Emerg Med. 54(5):704-731.

 

Ochoa-Gondar O et al. 2011. Comparison of three predictive rules for assessing severity in elderly patients with CAP. Int J Clin Pract. 65(11):1165-72.